NPI: 1033392709 · PHOENIX, AZ 85037 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/17/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/17/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 39,561 | $1.14M |
| 2019 | 35,035 | $1.10M |
| 2020 | 32,574 | $1.11M |
| 2021 | 28,561 | $1.20M |
| 2022 | 21,409 | $1.09M |
| 2023 | 15,998 | $947K |
| 2024 | 8,631 | $746K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 62,913 | 5,200 | $5.37M |
| 90945 | 24,699 | 836 | $744K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 30,150 | 2,732 | $632K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 753 | 412 | $516K |
| J1756 | Injection, iron sucrose, 1 mg | 9,435 | 2,587 | $59K |
| A4657 | Syringe, with or without needle, each | 18,559 | 3,283 | $2K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,382 | 255 | $735.84 |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,229 | 1,810 | $100.92 |
| 83970 | 1,000 | 817 | $33.09 | |
| 85041 | 1,389 | 1,139 | $4.32 | |
| 85048 | 1,383 | 1,135 | $3.63 | |
| 82728 | 1,084 | 885 | $2.79 | |
| 83550 | 613 | 503 | $1.79 | |
| 83540 | 1,134 | 924 | $1.33 | |
| 90674 | 171 | 155 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 284 | 258 | $0.00 |
| 90747 | 50 | 46 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 297 | 188 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 22 | 21 | $0.00 |
| 82947 | 119 | 91 | $0.00 | |
| 90662 | 90 | 74 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 3,898 | 322 | $0.00 |
| 90661 | 17 | 17 | $0.00 | |
| 82108 | 98 | 77 | $0.00 |